vs
MAXIMUS, INC.（MMS）与Roper Technologies（ROP）财务数据对比。点击上方公司名可切换其他公司
Roper Technologies的季度营收约是MAXIMUS, INC.的1.6倍（$2.1B vs $1.3B），Roper Technologies净利率更高（15.8% vs 7.0%，领先8.8%），Roper Technologies同比增速更快（11.3% vs -4.1%），Roper Technologies自由现金流更多（$507.0M vs $-250.7M），过去两年Roper Technologies的营收复合增速更高（10.5% vs -0.1%）
MAXIMUS是美国一家政府服务企业，业务覆盖美国、加拿大、英国等国家，为医疗补助、联邦医疗保险、医改、就业帮扶、学生贷款服务等各类政府项目提供行政及配套服务。公司总部位于弗吉尼亚州泰森斯，现有员工3.96万名，2024财年营收达53亿美元。
罗珀技术公司是一家专注于科技领域的控股企业，通过持有并运营多家不同细分赛道的科技公司，在科技产业投资与资产管理领域形成了成熟的业务体系，在全球相关市场具备较高的行业影响力。
MMS vs ROP — 直观对比
营收规模更大
ROP
是对方的1.6倍
$1.3B
营收增速更快
ROP
高出15.4%
-4.1%
净利率更高
ROP
高出8.8%
7.0%
自由现金流更多
ROP
多$757.7M
$-250.7M
两年增速更快
ROP
近两年复合增速
-0.1%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $2.1B |
| 净利润 | $93.9M | $331.0M |
| 毛利率 | 23.7% | 69.4% |
| 营业利润率 | 10.9% | 27.2% |
| 净利率 | 7.0% | 15.8% |
| 营收同比 | -4.1% | 11.3% |
| 净利润同比 | 128.0% | 53.7% |
| 每股收益（稀释后） | $1.70 | $4.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MMSROP
| Q1 26 | — | $2.1B | ||
| Q4 25 | $1.3B | $2.1B | ||
| Q3 25 | $1.3B | $2.0B | ||
| Q2 25 | $1.3B | $1.9B | ||
| Q1 25 | $1.4B | $1.9B | ||
| Q4 24 | $1.4B | $1.9B | ||
| Q3 24 | $1.3B | $1.8B | ||
| Q2 24 | $1.3B | $1.7B |
净利润MMSROP
| Q1 26 | — | $331.0M | ||
| Q4 25 | $93.9M | $428.4M | ||
| Q3 25 | $75.3M | $398.5M | ||
| Q2 25 | $106.0M | $378.3M | ||
| Q1 25 | $96.6M | $331.1M | ||
| Q4 24 | $41.2M | $462.3M | ||
| Q3 24 | $72.5M | $367.9M | ||
| Q2 24 | $89.8M | $337.1M |
毛利率MMSROP
| Q1 26 | — | 69.4% | ||
| Q4 25 | 23.7% | 69.5% | ||
| Q3 25 | 25.3% | 69.5% | ||
| Q2 25 | 26.7% | 69.2% | ||
| Q1 25 | 24.9% | 68.7% | ||
| Q4 24 | 21.5% | 68.3% | ||
| Q3 24 | 22.9% | 69.2% | ||
| Q2 24 | 25.3% | 69.5% |
营业利润率MMSROP
| Q1 26 | — | 27.2% | ||
| Q4 25 | 10.9% | 28.6% | ||
| Q3 25 | 9.3% | 28.4% | ||
| Q2 25 | 12.3% | 28.2% | ||
| Q1 25 | 11.2% | 27.9% | ||
| Q4 24 | 6.2% | 28.0% | ||
| Q3 24 | 8.5% | 28.1% | ||
| Q2 24 | 10.8% | 28.8% |
净利率MMSROP
| Q1 26 | — | 15.8% | ||
| Q4 25 | 7.0% | 20.8% | ||
| Q3 25 | 5.7% | 19.8% | ||
| Q2 25 | 7.9% | 19.5% | ||
| Q1 25 | 7.1% | 17.6% | ||
| Q4 24 | 2.9% | 24.6% | ||
| Q3 24 | 5.5% | 20.8% | ||
| Q2 24 | 6.8% | 19.6% |
每股收益（稀释后）MMSROP
| Q1 26 | — | $4.87 | ||
| Q4 25 | $1.70 | $3.97 | ||
| Q3 25 | $1.27 | $3.68 | ||
| Q2 25 | $1.86 | $3.49 | ||
| Q1 25 | $1.69 | $3.06 | ||
| Q4 24 | $0.69 | $4.29 | ||
| Q3 24 | $1.18 | $3.40 | ||
| Q2 24 | $1.46 | $3.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $137.6M | $382.9M |
| 总债务越低越好 | — | $9.7B |
| 股东权益账面价值 | $1.7B | $18.8B |
| 总资产 | $4.2B | $34.6B |
| 负债/权益比越低杠杆越低 | — | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资MMSROP
| Q1 26 | — | $382.9M | ||
| Q4 25 | $137.6M | $297.4M | ||
| Q3 25 | $222.4M | $320.0M | ||
| Q2 25 | $59.8M | $242.4M | ||
| Q1 25 | $108.1M | $372.8M | ||
| Q4 24 | $72.7M | $188.2M | ||
| Q3 24 | $183.1M | $269.6M | ||
| Q2 24 | $102.8M | $251.5M |
总债务MMSROP
| Q1 26 | — | $9.7B | ||
| Q4 25 | — | $9.3B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益MMSROP
| Q1 26 | — | $18.8B | ||
| Q4 25 | $1.7B | $19.9B | ||
| Q3 25 | $1.7B | $20.0B | ||
| Q2 25 | $1.8B | $19.6B | ||
| Q1 25 | $1.7B | $19.2B | ||
| Q4 24 | $1.6B | $18.9B | ||
| Q3 24 | $1.8B | $18.5B | ||
| Q2 24 | $1.8B | $18.1B |
总资产MMSROP
| Q1 26 | — | $34.6B | ||
| Q4 25 | $4.2B | $34.6B | ||
| Q3 25 | $4.1B | $34.6B | ||
| Q2 25 | $4.5B | $33.2B | ||
| Q1 25 | $4.2B | $31.4B | ||
| Q4 24 | $4.1B | $31.3B | ||
| Q3 24 | $4.1B | $31.6B | ||
| Q2 24 | $4.0B | $29.8B |
负债/权益比MMSROP
| Q1 26 | — | 0.52× | ||
| Q4 25 | — | 0.47× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-244.4M | — |
| 自由现金流经营现金流 - 资本支出 | $-250.7M | $507.0M |
| 自由现金流率自由现金流/营收 | -18.6% | 24.2% |
| 资本支出强度资本支出/营收 | 0.5% | 0.5% |
| 现金转化率经营现金流/净利润 | -2.60× | — |
| 过去12个月自由现金流最近4个季度 | $218.5M | — |
8季度趋势，按日历期对齐
经营现金流MMSROP
| Q1 26 | — | — | ||
| Q4 25 | $-244.4M | $738.0M | ||
| Q3 25 | $649.4M | $869.5M | ||
| Q2 25 | $-182.7M | $404.1M | ||
| Q1 25 | $42.7M | $528.7M | ||
| Q4 24 | $-80.0M | $722.2M | ||
| Q3 24 | $163.8M | $755.4M | ||
| Q2 24 | $199.3M | $384.1M |
自由现金流MMSROP
| Q1 26 | — | $507.0M | ||
| Q4 25 | $-250.7M | — | ||
| Q3 25 | $641.8M | — | ||
| Q2 25 | $-198.2M | — | ||
| Q1 25 | $25.5M | — | ||
| Q4 24 | $-103.0M | — | ||
| Q3 24 | $131.9M | — | ||
| Q2 24 | $164.6M | — |
自由现金流率MMSROP
| Q1 26 | — | 24.2% | ||
| Q4 25 | -18.6% | — | ||
| Q3 25 | 48.7% | — | ||
| Q2 25 | -14.7% | — | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | -7.3% | — | ||
| Q3 24 | 10.0% | — | ||
| Q2 24 | 12.5% | — |
资本支出强度MMSROP
| Q1 26 | — | 0.5% | ||
| Q4 25 | 0.5% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.4% | — | ||
| Q2 24 | 2.6% | — |
现金转化率MMSROP
| Q1 26 | — | — | ||
| Q4 25 | -2.60× | 1.72× | ||
| Q3 25 | 8.63× | 2.18× | ||
| Q2 25 | -1.72× | 1.07× | ||
| Q1 25 | 0.44× | 1.60× | ||
| Q4 24 | -1.94× | 1.56× | ||
| Q3 24 | 2.26× | 2.05× | ||
| Q2 24 | 2.22× | 1.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MMS
| Clinical Services | $523.7M | 39% |
| Cost Plus Contracts | $386.4M | 29% |
| Outside The United States | $143.2M | 11% |
| International Government Agencies | $141.0M | 10% |
| Technology Solutions | $74.8M | 6% |
| Employment And Other | $70.2M | 5% |
| Other Including Local Municipalities And Commercial Customers | $17.6M | 1% |
ROP
暂无分部数据
